ImmuCell Corporation (ICCC)
ICCC Stock Price Chart
Explore ImmuCell Corporation interactive price chart. Choose custom timeframes to analyze ICCC price movements and trends.
ICCC Company Profile
Discover essential business fundamentals and corporate details for ImmuCell Corporation (ICCC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
5 May 1987
Employees
69.00
Website
https://immucell.comCEO
Michael F. Brigham
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
ICCC Financial Timeline
Browse a chronological timeline of ImmuCell Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 May 2026
Upcoming earnings on 23 Feb 2026
Upcoming earnings on 12 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at $0.06 , while revenue for the quarter reached $6.44M .
Earnings released on 14 May 2025
EPS came in at $0.16 , while revenue for the quarter reached $8.07M .
Earnings released on 25 Feb 2025
EPS came in at $0.06 , while revenue for the quarter reached $7.75M .
Earnings released on 13 Nov 2024
EPS came in at -$0.09 , while revenue for the quarter reached $6.01M .
Earnings released on 13 Aug 2024
EPS came in at -$0.20 , while revenue for the quarter reached $5.47M , beating expectations by +1.35%.
Earnings released on 14 May 2024
EPS came in at -$0.06 , while revenue for the quarter reached $7.26M , beating expectations by +34.40%.
Earnings released on 27 Feb 2024
EPS came in at -$0.15 , while revenue for the quarter reached $5.10M , missing expectations by -5.63%.
Earnings released on 13 Nov 2023
EPS came in at -$0.12 , while revenue for the quarter reached $5.40M , missing expectations by -0.06%.
Earnings released on 10 Aug 2023
EPS came in at -$0.18 , while revenue for the quarter reached $3.53M , missing expectations by -34.58%.
Earnings released on 11 May 2023
EPS came in at -$0.30 , while revenue for the quarter reached $3.45M , missing expectations by -36.18%.
Earnings released on 21 Feb 2023
EPS came in at -$0.22 , while revenue for the quarter reached $3.91M , missing expectations by -27.58%.
Earnings released on 21 Nov 2022
EPS came in at -$0.08 , while revenue for the quarter reached $4.80M , missing expectations by -11.19%.
Earnings released on 11 Aug 2022
EPS came in at -$0.09 , while revenue for the quarter reached $3.86M , missing expectations by -28.49%.
Earnings released on 12 May 2022
EPS came in at $0.09 , while revenue for the quarter reached $6.00M , beating expectations by +11.11%.
Earnings released on 22 Feb 2022
EPS came in at $0.01 surpassing the estimated -$0.01 by +200.00%, while revenue for the quarter reached $5.44M , beating expectations by +0.81%.
Earnings released on 15 Nov 2021
EPS came in at $0.02 surpassing the estimated -$0.06 by +133.33%, while revenue for the quarter reached $5.15M , beating expectations by +43.30%.
Earnings released on 12 Aug 2021
EPS came in at $0.02 surpassing the estimated -$0.08 by +125.00%, while revenue for the quarter reached $4.54M , beating expectations by +39.19%.
Earnings released on 13 May 2021
EPS came in at -$0.06 falling short of the estimated $0.05 by -220.00%, while revenue for the quarter reached $4.11M , missing expectations by -23.96%.
Earnings released on 22 Feb 2021
EPS came in at $0.03 surpassing the estimated $0.01 by +174.98%, while revenue for the quarter reached $3.74M , missing expectations by -59.60%.
Earnings released on 12 Nov 2020
EPS came in at -$0.04 surpassing the estimated -$0.08 by +50.00%, while revenue for the quarter reached $3.72M , missing expectations by -25.93%.
ICCC Stock Performance
Access detailed ICCC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.